Perspective Therapeutics CATX
NYSE CATX
$2.73 +0.12 (+4.39%)
As of: Sep 30, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Loans - Net (2022)

Updated

Perspective Therapeutics' Loans - Net was $6.11 million in Q4 2022.

Analysis

Perspective Therapeutics (CATX) Loans - Net (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Loans - Net (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Perspective Therapeutics 298.91 Mn 298.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 6.11 Mn
API Access

Perspective Therapeutics Loans - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=loans-net&ticker=CATX&period=max&api_key=YOUR_API_KEY